Deeper understanding of mechanisms contributing to sepsis-induced myocardial dysfunction

被引:12
|
作者
Walley, Keith R. [1 ]
机构
[1] Univ British Columbia, St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC V6Z 1Y6, Canada
来源
CRITICAL CARE | 2014年 / 18卷 / 03期
关键词
CARDIOMYOCYTE CONTRACTILITY; ICAM-1; ALPHA; MICE;
D O I
10.1186/cc13853
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The inflammatory response of sepsis results in organ dysfunction, including myocardial dysfunction. Myocardial dysfunction is particularly important in patients with severe septic shock who progress to a hypodynamic pre-terminal phase. Multiple aspects of this septic inflammatory response contribute to the pathogenesis of decreased ventricular contractility. Inflammatory cytokines released by inflammatory cells contribute as does nitric oxide released by vascular endothelium and by cardiomyocytes. Endotoxins and other pathogen molecules induce an intramyocardial inflammatory response by binding Toll-like receptors on cardiomyocytes that then signal via NF-kappa B. These processes alter cardiomyocyte depolarization and, therefore, contractility. The particular role of the cardiomyocyte sodium current has not been characterized. Now new information suggests that the septic inflammatory response impairs normal depolarization by altering the cardiomyocyte sodium current. This results in decreased ventricular contractility. This is important because new targets for therapeutic intervention can be considered and new approaches to evaluation of this problem can be contemplated.
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Role of interleukin-33 in sepsis-induced myocardial dysfunction
    Choe, Yoonmi
    Kao, Raymond
    Xenocostas, Anargyros
    Martin, Claudio M.
    Rui, Tao
    FASEB JOURNAL, 2012, 26
  • [32] Loss of Hepatic Angiotensinogen Attenuates Sepsis-Induced Myocardial Dysfunction
    Rong, Jiabing
    Tao, Xinran
    Lin, Yao
    Zheng, Haiqiong
    Ning, Le
    Lu, Hong S.
    Daugherty, Alan
    Shi, Peng
    Mullick, Adam E.
    Chen, Sicong
    Zhang, Zhaocai
    Xu, Yinchuan
    Wang, Jian'an
    CIRCULATION RESEARCH, 2021, 129 (05) : 547 - 564
  • [33] Sepsis-induced myocardial dysfunction and myocardial protection from ischemia/reperfusion injury
    McDonough, KH
    Virag, JI
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 : 23 - 32
  • [34] Sepsis-induced brain dysfunction
    Adam, Nicolas
    Kandelman, Stanislas
    Mantz, Jean
    Chretien, Fabrice
    Sharshar, Tarek
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2013, 11 (02) : 211 - 221
  • [35] Understanding sepsis-induced lymphopenia
    Puthalakath, H.
    Doerflinger, M.
    Pellegrini, M.
    Hotchkiss, R.
    Nedeva, C.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 504 - 504
  • [36] Role of TXNIP/NLRP3 in sepsis-induced myocardial dysfunction
    Yang, Chun
    Xia, Wan
    Liu, Xiaolin
    Lin, Jian
    Wu, Aiping
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 44 (02) : 417 - 426
  • [37] Sepsis-Induced Myocardial Dysfunction and Mammalian Target of Rapamycin Signalling Pathways
    Walley, Keith R.
    CANADIAN JOURNAL OF CARDIOLOGY, 2019, 35 (07) : 809 - 812
  • [38] Role of the mTOR Signalling Pathway in Human Sepsis-Induced Myocardial Dysfunction
    Cheng, Wei
    Long, Yun
    Wang, Hao
    Han, Wen
    Zhang, Jiahui
    Cui, Na
    CANADIAN JOURNAL OF CARDIOLOGY, 2019, 35 (07) : 875 - 883
  • [39] ELUCIDATING THE ROLE OF REVERSIBLE PROTEIN PHOSPHORYLATION IN SEPSIS-INDUCED MYOCARDIAL DYSFUNCTION
    Lorts, Angela
    Burroughs, Timothy
    Shanley, Thomas P.
    SHOCK, 2009, 32 (01): : 49 - 54
  • [40] A bibliometric analysis of sepsis-induced myocardial dysfunction from 2002 to 2022
    Yao, Hanyi
    Liu, Shufang
    Zhang, Zhiyu
    Xiao, Zixi
    Li, Dongping
    Yi, Zhangqing
    Huang, Yuyang
    Zhou, Haojie
    Yang, Yifeng
    Zhang, Weizhi
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10